Cite Score:
1.77
ELSEVIER SCOPUS

Von Hippel-Lindau Disease: A New Approach to an Old Problem

AUTHORS

Ali Tootee 1 , Shirin Hasani- Ranjbar 1 , *

AUTHORS INFORMATION

1 Tehran University of Medical Sciences, Endocrinology and Metabolism Research Institute, Shariati Hospital, sh_hasani@sina.tums.ac.ir, IR Iran

How to Cite: Tootee A, Hasani- Ranjbar S. Von Hippel-Lindau Disease: A New Approach to an Old Problem, Int J Endocrinol Metab. Online ahead of Print ; 10(4):619-624. doi: 10.5812/ijem.4510.

ARTICLE INFORMATION

International Journal of Endocrinology and Metabolism: 10 (4); 619-624
Published Online: September 29, 2012
Article Type: Review Article
Received: February 15, 2012
Accepted: May 7, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Von Hippel-Lindau (VHL) disease is a hereditary, autosomal dominant syndrome which is manifested by a range of different benign and malignant tumors. This disease can present with different clinical presentations such as; retinal angioma (RA), hemangioblastoma (HB) of the central nervous system (CNS), pheochromocytoma (Pheo), and epididymal cystadenoma. Tumors are usually accompanied with cysts.

Objectives: As the disease can display different clinical presentations, which are mainly unspecific, and considering the importance of an early diagnosis and the proper and early management of it, this study was carried out to present a general overview of VHL. Moreover, the present article reviews screening methods and emphasizes the need for increasing the awareness of different health care professionals to diagnose and refer the patients in the early stages.

Materials and Methods: A thorough search of internet medical databases, such as PubMed, was carried out on known or suggested; clinical presentations, pathogenesis, screening, causes and criteria for diagnosis of patients and their referrals.

Results: Our research demonstrated that VHL is caused by a mutation in the von Hippel-Lindau (VHL) gene. It also showed that different screening methods can be utilized for the early diagnosis and referral of patients. Different clinical presentations of the disease are also elaborated in some detail and their treatment options are discussed.

Conclusions: Considering the need for a multidisciplinary approach to VHL, especially, given the number of cases which have been reported and diagnosed in Iran, it is of great importance that clinicians remain vigilant in order to identify cases that present with clinical characteristics of the disease, and that they are prompt in referring them to a multidisciplinary VHL clinic. It is also important to establish links with existing VHL Family Alliances and other related organizations around the world.

Keywords

Von Hippel-Lindau Disease Pheochromocytoma

© 2012, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: